AMENDMENT TO LICENSE AGREEMENT REGARDING SUBLICENSINGLicense Agreement Regarding Sublicensing • March 13th, 2009 • Albany Molecular Research Inc • Services-commercial physical & biological research
THIS AMENDMENT TO LICENSE AGREEMENT REGARDING SUBLICENSING (this “Agreement”), dated as of this 18th day of November, 2008, but effective as of the Effective Date, is hereby entered into by and between sanofi-aventis U.S. LLC, a Delaware limited liability company with offices located at 55 Corporate Drive, Bridgewater, NJ 08807 (“sanofi-aventis U.S.”) and Albany Molecular Research, Inc., a Delaware corporation with offices located at 26 Corporate Circle, Albany, New York 12203, with its wholly-owned subsidiary, AMR Technology, Inc., a Vermont corporation with offices located at 5429 Main Street, Manchester, Vermont 05255, (collectively “AMRI”). Sanofi-aventis U.S. and AMRI are sometimes referred to individually as a “Party” and collectively as the “Parties.”
